Heart Test Laboratories, Inc. Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q1 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Heart Test Laboratories, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q1 2022 to Q2 2024.
  • Heart Test Laboratories, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending July 31, 2024 was $11.7M, a 13.5% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $11.7M +$1.39M +13.5% Jul 31, 2024 10-Q 2024-09-12
Q1 2024 $11.4M +$1.68M +17.3% Apr 30, 2024 10-Q 2024-09-12
Q4 2023 $11M +$1.52M +16.1% Jan 31, 2024 10-Q 2024-03-14
Q3 2023 $10.6M +$1.5M +16.6% Oct 31, 2023 10-Q 2023-12-14
Q2 2023 $10.3M +$1.59M +18.3% Jul 31, 2023 10-Q 2023-09-14
Q1 2023 $9.7M +$1.31M +15.7% Apr 30, 2023 10-K 2024-07-29
Q4 2022 $9.45M Jan 31, 2023 10-Q 2023-03-16
Q3 2022 $9.06M Oct 31, 2022 10-Q 2022-12-15
Q2 2022 $8.68M Jul 31, 2022 10-Q 2022-09-12
Q1 2022 $8.39M Apr 30, 2022 10-K 2023-07-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.